We’ve been at it in Britain for a very long time… innovation, invention, turning new technologies into business ideas. We were there, leading from the front, in the first Industrial Revolution and I believe we’re right back in the driving seat now, at the beginning of the fourth.
Today, we’re witnessing an acceleration in progress, driven by the convergence of a whole range of different innovation cycles – digital, physical and biological. We’re seeing an explosion of new ideas, markets and businesses in the ever-evolving space between healthcare, genetics, AI, materials science and space technology. Big corporations know the way things are heading, they know serious disruption is on the horizon but it’s hard for them to change fast enough.
That’s why they’re looking to invest in new companies and new concepts to bring them the innovation they need.
And that’s where we come in – our EIS Funds is here to boost these exciting new companies and concepts at the beginning of their journey.
Our team works to identify the winning ideas and winning teams operating in the 4IR space and work with them to realise their huge growth potential.
Charles Breese, Director at Newable Ventures Limited.
For more information on how to invest in our Funds and the opportunity to build your own investment portfolio, click here;
Newable Ventures Limited (FRN 795277) is an Appointed Representative of Larpent Newton & Co Ltd. Larpent Newton & Co Ltd is authorised and regulated by the Financial Conduct Authority, FRN 141275.
Neither Newable Capital Limited nor Newable Private Investing Limited are Authorised and Regulated by the Financial Conduct Authority. Risk warning: Your capital is at risk. Investing in early stage companies involves risks including loss of capital, illiquidity, lack of dividends and dilution. Newable Ventures Limited does not give tax or investment advice.
The availability of tax relief depends on individual investors’ circumstances, and on investee companies’ qualifying status, both of which may be subject to change. If you are in doubt about eligibility for tax reliefs or the tax treatment of your investment, you should seek independent tax advice.